Current study suggests that reduction of cellular stress is the another potential molecular mechanism underlying FGF1 treatment for DN, which further replenishes the molecular mechanism underlying FGF1 treatment for DN. This evidence concerns the gene FGF1 and liver dysplastic nodule.